Health & Medicine
-
Biogen Inc. Wins Approval for its First Pill to Treat MS
Biogen Inc, makers of multiple sclerosis (MS) drugs Avonex and Tysabri, have recently won approval from the Food and Drug Administration for its first pill for the disease: Tecfidera.
Latest Research Articles
-
WHO Reports Two More Deaths From SARS-like Novel Coronavirus (VIDEO)
-
Saliva Test can Predict Aggression Risk in Boys: Study
-
Perils of Social Isolation, How it Can Shorten Your Life
-
Shorter Shifts for Doctors Doesn't Equate to Improved Patient Care
-
Breath Study Shows Link Between Obesity And Microorganisms Living In The Gut
-
Being Socially Isolated Linked with Early Death Risk
-
Temporary Henna Tattoos can Cause Allergic Reactions: FDA
-
Using Songbirds, Researchers Demonstrate That Sleeping Consolidates Learning (VIDEO)
-
Revolutionary New Wound Dressing Will Save Burn Victims' Lives
-
Massachusetts Pharmacy Company Recalling Sterile Products
-
Deadly Virus Sample Goes Missing From Texas Lab
-
Vial Containing Virus that Causes Hemorrhagic Fever Missing from Texas Lab